Uncoupler therapy for NAFLD: is flushing a possible harbinger of a safety concern? - Authors' reply
Lancet Gastroenterol Hepatol
.
2024 Feb;9(2):105-106.
doi: 10.1016/S2468-1253(23)00446-6.
Authors
Mazen Noureddin
1
,
Diane Jorkasky
2
,
Shaharyar Khan
3
,
Arun J Sanyal
4
Affiliations
1
Houston Research Institute, Houston Methodist Hospital, Houston, TX 77079, USA. Electronic address: noureddinmd@houstonresearchinstitute.com.
2
Philadelphia, PA, USA.
3
Rivus Pharmaceuticals, Charlottesville, VA, USA.
4
Stravitz-Sanyal Institute of Liver Disease and Metabolic Health, Department of Internal Medicine, VCU School of Medicine, Richmond, VA, USA.
PMID:
38215776
DOI:
10.1016/S2468-1253(23)00446-6
No abstract available
Publication types
Letter
MeSH terms
Humans
Non-alcoholic Fatty Liver Disease*